This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Madani, N.
Right arrow Articles by Kabat, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Madani, N.
Right arrow Articles by Kabat, D.

 Previous Article  |  Next Article 

Journal of Virology, November 2002, p. 11133-11138, Vol. 76, No. 21
0022-538X/02/$04.00+0     DOI: 10.1128/JVI.76.21.11133-11138.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Implication of the Lymphocyte-Specific Nuclear Body Protein Sp140 in an Innate Response to Human Immunodeficiency Virus Type 1

Navid Madani,1,{dagger} Robert Millette,1 Emily J. Platt,1 Mariana Marin,1 Susan L. Kozak,1 Donald B. Bloch,2 and David Kabat1*

Department of Biochemistry and Molecular Biology, Oregon Health and Science University, Portland, Oregon 97201-3098,1 Department of Medicine, Massachusetts General Hospital, Charlestown, Massachusetts 021292

Received 5 April 2002/ Accepted 18 July 2002

The viral infectivity factor (Vif) of human immunodeficiency virus type 1 (HIV-1) neutralizes an unidentified antiviral pathway that occurs only in nonpermissive (NP) cells. Using a yeast two-hybrid screen of a human lymphocyte cDNA library, we identified several potential Vif partners. One, the nuclear body protein Sp140, was found specifically in all NP cells (n = 12 cell lines tested; P <= 0.001), and HIV-1 infection induced its partial dispersal from nuclear bodies into cytosolic colocalization with Vif. Our results implicate Sp140 in a response to HIV-1 that may be related to or coordinated with the pathway that inactivates HIV-1 lacking vif.


* Corresponding author. Mailing address: Department of Biochemistry and Molecular Biology, Oregon Health and Science University, Portland, OR 97201-3098. Phone: (503) 494-8442. Fax: (503) 494-8393. E-mail: kabat{at}ohsu.edu.

{dagger} Present address: Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115.


Journal of Virology, November 2002, p. 11133-11138, Vol. 76, No. 21
0022-538X/02/$04.00+0     DOI: 10.1128/JVI.76.21.11133-11138.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Henriet, S., Mercenne, G., Bernacchi, S., Paillart, J.-C., Marquet, R. (2009). Tumultuous Relationship between the Human Immunodeficiency Virus Type 1 Viral Infectivity Factor (Vif) and the Human APOBEC-3G and APOBEC-3F Restriction Factors. Microbiol. Mol. Biol. Rev. 73: 211-232 [Abstract] [Full Text]  
  • Dang, Y., Siew, L. M., Zheng, Y.-H. (2008). APOBEC3G Is Degraded by the Proteasomal Pathway in a Vif-dependent Manner without Being Polyubiquitylated. J. Biol. Chem. 283: 13124-13131 [Abstract] [Full Text]  
  • Wichroski, M. J., Ichiyama, K., Rana, T. M. (2005). Analysis of HIV-1 Viral Infectivity Factor-mediated Proteasome-dependent Depletion of APOBEC3G: CORRELATING FUNCTION AND SUBCELLULAR LOCALIZATION. J. Biol. Chem. 280: 8387-8396 [Abstract] [Full Text]  
  • Feng, F., Davis, A., Lake, J.-A., Carr, J., Xia, W., Burrell, C., Li, P. (2004). Ring Finger Protein ZIN Interacts with Human Immunodeficiency Virus Type 1 Vif. J. Virol. 78: 10574-10581 [Abstract] [Full Text]  
  • Kao, S., Khan, M. A., Miyagi, E., Plishka, R., Buckler-White, A., Strebel, K. (2003). The Human Immunodeficiency Virus Type 1 Vif Protein Reduces Intracellular Expression and Inhibits Packaging of APOBEC3G (CEM15), a Cellular Inhibitor of Virus Infectivity. J. Virol. 77: 11398-11407 [Abstract] [Full Text]